Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.5010
-0.0188 (-3.62%)
At close: Jul 8, 2026, 4:00 PM EDT
0.5002
-0.0008 (-0.16%)
After-hours: Jul 8, 2026, 5:58 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.74 million as of July 8, 2026. Its market cap has increased by 212.67% in one year.
Market Cap
16.74M
Enterprise Value
-33.66M
1-Year Change
212.67%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.74M, a decrease of -74.36%. That is a compound annual growth rate of -24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 16.74M | -43.80% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 19.40M |
| Palatin Technologies | 19.32M |
| AEON Biopharma | 18.42M |
| Allarity Therapeutics | 17.98M |
| Quince Therapeutics | 17.11M |
| Werewolf Therapeutics | 16.72M |
| GT Biopharma | 16.59M |
| BioVie | 16.29M |